Conexus Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 31.00 K
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Conexus Biotech
Conexus Biotech Private Limited (CBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 July 2022 (Two years and seven months 4 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 31.00 K , as per Ministry of Corporate Affairs (MCA) records.
Deependra Kumar and Vindhyavasni Pandey serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110UP2022PTC168086
- Company No.
168086
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2022
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Conexus Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deependra Kumar  | Director | 22-Jul-2022 | Current |
| Vindhyavasni Pandey | Director | 22-Jul-2022 | Current |
Financial Performance of Conexus Biotech.
Enhance accessibility to Conexus Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Conexus Biotech?
Unlock access to Conexus Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Codeon Infosystem Private LimitedDeependra Kumar and Vindhyavasni Pandey are mutual person
Educloud Consultants Private LimitedDeependra Kumar and Vindhyavasni Pandey are mutual person
- Aarogya City Hospital Foundation
Deependra Kumar and Vindhyavasni Pandey are mutual person
- Ayushmann Lifesciences Private Limited
Vindhyavasni Pandey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Conexus Biotech?
Conexus Biotech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Conexus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Conexus Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.